Your Health. Your Family. Your Choice.
Administered by: Unknown Purchased by: Unknown
Life Threatening? No
Write-up: Information was obtained on request by the company from the agency via a public case details form concerning a 12 year old female who on 06-MAR-2008 was vaccinated with first dose of GARDASIL (lot # not reported). On an unspecified date she received second dose (lot # not reported). On 11-SEP-2008 she received third dose of GARDASIL (lot # not reported). On 06-MAR-2008 after first injection she started feeling unwell with a minor headaches. After second injection she experienced severe headaches consistent, progressing to severe intense migraines, neck and back pain, pins and needles in hands, face and dizzy spells and loss of balance. After third injection she experienced leg and back pain (wheelchair was needed as unable to walk unaided), migraine, back, leg and neck worse and rid pain. Four days after last injection she experienced foot pain sore ankle with swelling, pins and needles, foot cold and unable to walk properly. The patient was treated with PANADEINE FORTE, diazepam, MOBIC, physiotherapy, endeplo and NAPROSYN SR 750. At the time on the report the patient had not recovered from headache, abasia, balance disorder, dizziness, migraine and paraesthesia. The agency considered that headache, abasia, balance disorder, dizziness, migraine and paraesthesia were possible related to therapy with GARDASIL. The original reporting source was not provided. Follow up information has been received from agency who considered the events of leg pain and back pain (wheelchair was needed to walk unaided) to be incapacitating/disabling. No further information is available.
Copyright © 2018 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166